Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination and otitis media.

P Karma1

  • 1Department of Otorhinolaryngology, Helsinki University Central Hospital, Helsinki, Finland. pekka.karma@hus.fi

ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|May 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recommended treatment of acute otitis].

Duodecim; laaketieteellinen aikakauskirja·2002
Same author

[Treatment of acute otitis media under discussion].

Duodecim; laaketieteellinen aikakauskirja·2001
Same author

The pure-tone hearing thresholds of otologically healthy 14-year-old children.

Audiology : official organ of the International Society of Audiology·2001
Same author

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

The New England journal of medicine·2001
Same author

Clinical outcome of acute pneumococcal otitis media and serum antibody responses to pneumococcal pneumolysin and polysaccharides in children.

Acta oto-laryngologica. Supplementum·2000
Same author

Factors associated with the development of recurrent acute otitis media--the significance of choosing the right and accurate dependent and independent variables in the multivariate analysis.

Acta oto-laryngologica. Supplementum·2000
Same journal

Quality-of-Life and Cosmetic Outcomes With Endoscopic Versus Microscopic Endaural and Postauricular Type I Tympanoplasty.

ORL; journal for oto-rhino-laryngology and its related specialties·2026
Same journal

Posterior Nasal Neurectomy for Allergic and Non-Allergic Rhinitis: Efficacy, Safety, and Predictive Factors.

ORL; journal for oto-rhino-laryngology and its related specialties·2026
Same journal

COGNITIVE FUNCTION AND OLFACTORY ABILITY IN THE ELDERLY: AN ASSOCIATION ANALYSIS.

ORL; journal for oto-rhino-laryngology and its related specialties·2026
Same journal

Risk Factors for Intubation-Related Laryngeal Granulomas: A Prospective Study in Surgical Patients.

ORL; journal for oto-rhino-laryngology and its related specialties·2026
Same journal

Surface Texture of Taste Carriers Modulates Bitter Taste Identification.

ORL; journal for oto-rhino-laryngology and its related specialties·2026
Same journal

Characteristic analysis of laryngopharyngeal reflux-related mucosal vessels under narrow band imaging laryngoscopy.

ORL; journal for oto-rhino-laryngology and its related specialties·2026
See all related articles

New conjugate vaccines show promise in preventing bacterial acute otitis media (AOM) in infants. Further research is needed for vaccines against other common AOM pathogens like Haemophilus influenzae and Moraxella catarrhalis.

Area of Science:

  • Pediatrics
  • Immunology
  • Vaccinology

Background:

  • Acute otitis media (AOM) is a common childhood infection often caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
  • Previous attempts using pneumococcal capsular polysaccharide vaccines were unsuccessful in preventing AOM.
  • Developing effective vaccines against AOM remains a significant public health challenge.

Purpose of the Study:

  • To review the current status and future prospects of vaccine development for preventing acute otitis media.
  • To evaluate the efficacy of recent conjugate vaccines against pneumococcal AOM.
  • To discuss alternative strategies for AOM prevention, including those for non-encapsulated bacteria and viral causes.

Main Methods:

  • Review of clinical trials and scientific literature on AOM vaccines.

Related Experiment Videos

  • Analysis of immunogenicity and efficacy data for pneumococcal conjugate vaccines.
  • Exploration of ongoing vaccine development for Haemophilus influenzae and Moraxella catarrhalis.

    • Main Results:

    • A heptavalent pneumococcal CRM 197 conjugate vaccine demonstrated a 57% reduction in vaccine-type pneumococcal AOM episodes in infants.
    • Influenza vaccines have shown potential for preventing AOM during viral epidemics.
    • Passive immunoprophylaxis has not yet proven successful for AOM prevention.

    Conclusions:

    • Pneumococcal conjugate vaccines represent a significant advancement in preventing AOM caused by specific Streptococcus pneumoniae serotypes.
    • Vaccine development for non-encapsulated Haemophilus influenzae and Moraxella catarrhalis is ongoing.
    • Future strategies may involve mucosal immunization and advancements in DNA and gene technology for AOM prevention.